In 2019 an FDA research team bought tattoo and permanent makeup inks the same way a studio would, sealed and within shelf life, and did the one thing almost nobody in the supply chain ever does. They opened 75 bottles onto culture plates and waited to see what grew.
Something grew in nearly half of them.
The detail that should stop a med spa owner mid-scroll is this one: 49 of those bottles carried a sterility claim on the label, and 16 of the 49 grew microorganisms anyway. The label said sterile. The plate said otherwise, roughly one bottle in three.
The short version. The study is not really about ink. It is about the gap between a claim and a measurement.
- The bottles were sealed. Contamination arrived from the factory, not the studio.
- The label was confident. Sterile, printed right on it.
- Only the culture knew. No visual inspection of a bottle can see a bacterial load.
Why does this land on the med spa, not the manufacturer?
Because permanent makeup breaks the skin, and once the skin is broken, everything in the chain of custody becomes the spa's problem in practice regardless of whose name is on the bottle. The client whose brow procedure goes wrong does not file a complaint with an ink factory. They post about the spa.
The FDA's own guidance to artists after this work was unglamorous and correct: you cannot tell by looking. A contaminated ink looks exactly like a clean one. Which is the same sentence, word for word, that applies to every surface in your treatment rooms.
What is the surface version of this study?
Run the parallel. A treatment chair that was wiped quickly with the wrong product, or with the right product wiped dry too early, looks identical to one cleaned at full label contact time. A magnification lamp handle touched by every client of the day looks the same at close of business as it did at open. The failure mode of the ink bottle, invisible contamination behind a confident claim, is the default state of every high-touch surface that is cleaned on trust.
The industry answer to the ink problem is culturing: measure the product, not the label. The surface-side equivalent is measurement too. An ATP swab reads the organic residue left on a surface after cleaning and returns a number in seconds. Precision matters here, so here is the honest boundary: ATP verifies the cleaning step. It does not certify sterility and it does not measure pathogen kill. It answers one question, was this surface actually cleaned, which happens to be the question a visual check cannot answer at all.
How should a spa act on this?
On product: buy inks from manufacturers who publish batch sterility testing, log lot numbers per client, and treat a sterility claim as a starting point rather than a conclusion. New York's inspection regime has been writing citations around exactly this kind of paperwork gap.
On surfaces: apply the same standard to your cleaning vendor that the FDA applied to the ink makers. A vendor saying "we deep clean everything" is a label. Ask what gets measured, where the readings are recorded, and whether you can see them. A vendor who welcomes that question is running a system. A vendor who is offended by it is asking you to extend the same trust those 16 bottles got.
The plate does not care about the label. That is the whole discipline in one sentence, and it applies to a $40 bottle of pigment and a 2,000 square foot spa in exactly the same way. Clean has a number, and anything without a number is a story.